A dynamic decision support tool for use in the design of bio-manufacturing facilities and processes

The effect of uncertainty in biopharmaceutical manufacturing can be a barrier to robust, scalable process design. The ideal is for a process in development to complete technology transfer to full scale manufacturing with no redevelopment costs or surprises. Essential to achieving this is a systematic method for analysing large complex datasets and extracting critical combinations of fluctuations that lead to product loss and scheduling delays. This thesis describes a dynamic database-driven decision-support tool to facilitate such efforts and identify robust optimal purification strategies to match the high productivity cell cultures whilst coping with uncertainties. The benefits of a databasedriven approach using MySQL (MySQL AB, Uppsala, Sweden) are harnessed to capture the process, business and risk features of multiple biopharmaceutical purification sequences in a multi-product facility and better manage the large datasets required for multiple processes, uncertainty analysis and optimisation. Principal component analysis combined with clustering algorithms are used to analyse the complex datasets from complete batch processes for biopharmaceuticals. The challenge of visualising the multidimensional nature of the dataset was addressed using hierarchical and k-means clustering as well as parallel co-ordinate plots to help identify process fingerprints and characteristics of clusters leading to facility fit issues. Industrially-relevant case studies are presented that focus on tech transfer challenges for therapeutic antibodies moving from early phase to late phase clinical trials.

[1]  Rafiqul Gani,et al.  Process synthesis and simulation strategies for integrated biochemical process design , 1996 .

[2]  Rachel Legmann,et al.  A predictive high‐throughput scale‐down model of monoclonal antibody production in CHO cells , 2009, Biotechnology and bioengineering.

[3]  J. Carson Introduction to modeling and simulation , 2005, Proceedings of the Winter Simulation Conference, 2005..

[4]  W. Velicer,et al.  Comparison of five rules for determining the number of components to retain. , 1986 .

[5]  Duncan Low,et al.  Future of antibody purification. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[6]  Gail Sofer Regulatory Trends Related to Process Validation , 2000 .

[7]  N J Titchener-Hooker,et al.  Economic comparison between conventional and disposables-based technology for the production of biopharmaceuticals. , 2001, Biotechnology and bioengineering.

[8]  Joe X. Zhou,et al.  Viral clearance using disposable systems in monoclonal antibody commercial downstream processing , 2008, Biotechnology and bioengineering.

[9]  Jeremy S. Conner,et al.  Application of Multivariate Analysis toward Biotech Processes: Case Study of a Cell‐Culture Unit Operation , 2007, Biotechnology progress.

[10]  Martyn S. Ray,et al.  Coulson and Richardson's Chemical Engineering Volume 6 (Design), 2nd Edition, by R.K. Sinnott, Pergamon Press, Oxford, UK (1993). 954 pages. ISBN 0‐08‐041865‐1. , 2008 .

[11]  R. Rummel Applied Factor Analysis , 1970 .

[12]  Anu Maria,et al.  Introduction to modeling and simulation , 1997, WSC '97.

[13]  N. Thornhill,et al.  Multidimensional Visualization and Clustering of Historical Process Data , 2006 .

[14]  Ray Farmer,et al.  Object-Oriented Systems Analysis and Design Using UML , 2001 .

[15]  P Dunnill,et al.  Prediction of the pilot-scale recovery of a recombinant yeast enzyme using integrated models. , 2001, Biotechnology and bioengineering.

[16]  Averill M. Law,et al.  Selecting simulation software for manufacturing applications , 1989, WSC '89.

[17]  Sunil Chhatre,et al.  Ultra scale‐down approach to correct dispersive and retentive effects in small‐scale columns when predicting larger scale elution profiles , 2009, Biotechnology progress.

[18]  R. Cattell The Scree Test For The Number Of Factors. , 1966, Multivariate behavioral research.

[19]  Suzanne S. Farid,et al.  Modelling of the biopharmaceutical drug development pathway and portfolio management , 2005, Comput. Chem. Eng..

[20]  T Shanklin,et al.  Selection of bioprocess simulation software for industrial applications. , 2001, Biotechnology and bioengineering.

[21]  Suzanne S Farid,et al.  Decision‐Support Tool for Assessing Biomanufacturing Strategies under Uncertainty: Stainless Steel versus Disposable Equipment for Clinical Trial Material Preparation , 2008, Biotechnology progress.

[22]  S. Hober,et al.  Protein A chromatography for antibody purification. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[23]  M. E. Pate,et al.  Principal Component Analysis of Nonlinear Chromatography , 2008, Biotechnology progress.

[24]  Gail Soler,et al.  Regulatory Trends Related to Process Validation , 2000 .

[25]  Kurt Brorson,et al.  Generic/matrix evaluation of SV40 clearance by anion exchange chromatography in flow‐through mode , 2003, Biotechnology and bioengineering.

[26]  Jeff Davis,et al.  Use of Process Data To Assess Chromatographic Performance in Production‐Scale Protein Purification Columns , 2003, Biotechnology progress.

[27]  G. Hale,et al.  Repeated cleaning of protein A affinity column with sodium hydroxide. , 1994, Journal of immunological methods.

[28]  M. Kamarck,et al.  Building biomanufacturing capacity—the chapter and verse , 2006, Nature Biotechnology.

[29]  Yuhong Zhou,et al.  A decisional-support tool to model the impact of regulatory compliance activities in the biomanufacturing industry , 2004, Comput. Chem. Eng..

[30]  J. Edward Jackson,et al.  A User's Guide to Principal Components. , 1991 .

[31]  Sunil Chhatre,et al.  The Integrated Simulation and Assessment of the Impacts of Process Change in Biotherapeutic Antibody Production , 2006, Biotechnology progress.

[32]  S Karri,et al.  A Tool for Modeling Strategic Decisions in Cell Culture Manufacturing , 2000, Biotechnology progress.

[33]  S. Qin,et al.  Selection of the Number of Principal Components: The Variance of the Reconstruction Error Criterion with a Comparison to Other Methods† , 1999 .

[34]  Rolf Danielsson,et al.  Alignment of chromatographic profiles for principal component analysis: a prerequisite for fingerprinting methods , 1994 .

[35]  Jochen Strube,et al.  Challenges in biotechnology production—generic processes and process optimization for monoclonal antibodies , 2005 .

[36]  S Gülich Protein engineering of an IgG-binding domain allows milder elution conditions during affinity chromatography , 2000 .

[37]  J. J. Stewart,et al.  Putting a price on biotechnology , 2001, Nature Biotechnology.

[38]  E. Keshavarz-Moore,et al.  A decision-support model for evaluating changes in biopharmaceutical manufacturing processes , 2007, Bioprocess and biosystems engineering.

[39]  Brian Hubbard,et al.  Downstream processing of monoclonal antibodies--application of platform approaches. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[40]  Suzanne S. Farid,et al.  Modelling biopharmaceutical manufacture: Design and implementation of SimBiopharma , 2007, Comput. Chem. Eng..

[41]  Miriam Monge,et al.  Biomanufacturing for the 21 st Century Designing a Concept Facility Based on Single-Use Systems , 2004 .

[42]  Patrick Thompson,et al.  Defining process design space for monoclonal antibody cell culture , 2010, Biotechnology and bioengineering.

[43]  D. Krahl,et al.  The Extend simulation environment , 2000, Proceeding of the 2001 Winter Simulation Conference (Cat. No.01CH37304).

[44]  Wei Wang,et al.  Protein aggregation and its inhibition in biopharmaceutics. , 2005, International journal of pharmaceutics.

[45]  David J Roush,et al.  Maximizing productivity of chromatography steps for purification of monoclonal antibodies , 2008, Biotechnology and bioengineering.

[46]  Suzanne S Farid,et al.  Fed‐batch and perfusion culture processes: Economic, environmental, and operational feasibility under uncertainty , 2013, Biotechnology and bioengineering.

[47]  Suzanne S Farid,et al.  A computer‐aided approach to compare the production economics of fed‐batch and perfusion culture under uncertainty , 2006, Biotechnology and bioengineering.

[48]  D. Bracewell,et al.  Principal Component Score Modeling for the Rapid Description of Chromatographic Separations , 2008, Biotechnology progress.

[49]  Ian Gosling Process simulation and modeling for industrial bioprocessing: Tools and techniques , 2005 .

[50]  X. Wang,et al.  Multidimensional Visualization of Principal Component Scores for Process Historical Data Analysis , 2004 .

[51]  M E Groep,et al.  Performance modeling and simulation of biochemical process sequences with interacting unit operations. , 2000, Biotechnology and bioengineering.

[52]  David W. Embley,et al.  Object-oriented systems analysis , 1992 .

[53]  E. Boschetti,et al.  Composite affinity sorbents and their cleaning in place. , 1990, Journal of chromatography.

[54]  J. Bonnerjea,et al.  Scale-up of monoclonal antibody purification processes. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[55]  John S. Carson,et al.  Modeling and simulation worldviews , 1993, WSC '93.

[56]  K E Willard,et al.  Probabilistic Analysis of Decision Trees Using Monte Carlo Simulation , 1986, Medical decision making : an international journal of the Society for Medical Decision Making.

[57]  Eric N M van Sprang,et al.  Multivariate data analysis on historical IPV production data for better process understanding and future improvements , 2010, Biotechnology and bioengineering.

[58]  Ashraf Amanullah,et al.  Novel micro‐bioreactor high throughput technology for cell culture process development: Reproducibility and scalability assessment of fed‐batch CHO cultures , 2010, Biotechnology and bioengineering.

[59]  Suzanne S Farid,et al.  Strategic Biopharmaceutical Portfolio Development: An Analysis of Constraint‐Induced Implications , 2008, Biotechnology progress.

[60]  Suzanne S Farid,et al.  Combining Multiple Quantitative and Qualitative Goals When Assessing Biomanufacturing Strategies under Uncertainty , 2008, Biotechnology progress.

[61]  Anurag S Rathore,et al.  Application of near‐infrared (NIR) spectroscopy for screening of raw materials used in the cell culture medium for the production of a recombinant therapeutic protein , 2009, Biotechnology progress.

[62]  R. W. Rozett,et al.  Methods of factor analysis of mass spectra , 1975 .

[63]  A. Arunakumari,et al.  Advances in Non-Protein A Purification Processes for Human Monoclonal Antibodies : In three non-affinity purification processes based on cation exchange capture with high binding capacity, applying a host cell protein exclusion strategy enabled robust scale up and better economics , 2009 .

[64]  Nigel J. Titchener-Hooker,et al.  A framework for assessing the solutions in chromatographic process design and operation for large-scale manufacture , 2006 .

[65]  Yuhong Zhou,et al.  Application of a Decision‐Support Tool to Assess Pooling Strategies in Perfusion Culture Processes under Uncertainty , 2008, Biotechnology progress.

[66]  Kurt Brorson,et al.  Bracketed generic inactivation of rodent retroviruses by low pH treatment for monoclonal antibodies and recombinant proteins. , 2003, Biotechnology and bioengineering.

[67]  K. Gernaey,et al.  Good modeling practice for PAT applications: Propagation of input uncertainty and sensitivity analysis , 2009, Biotechnology progress.

[68]  M Vanderlaan,et al.  Industrial Purification of Pharmaceutical Antibodies: Development, Operation, and Validation of Chromatography Processes , 2001, Biotechnology & genetic engineering reviews.

[69]  F. Steindl,et al.  Comparison of protein A affinity sorbents III. Life time study. , 2006, Journal of chromatography. A.

[70]  Mark Teeters,et al.  Predicting diafiltration solution compositions for final ultrafiltration/diafiltration steps of monoclonal antibodies , 2011, Biotechnology and bioengineering.

[71]  Paul J. Mcdonald,et al.  Fragments of protein A eluted during protein A affinity chromatography. , 2007, Journal of chromatography. A.

[72]  Brian Kelley,et al.  Very Large Scale Monoclonal Antibody Purification: The Case for Conventional Unit Operations , 2007, Biotechnology progress.

[73]  Seongkyu Yoon,et al.  Estimation of raw material performance in mammalian cell culture using near infrared spectra combined with chemometrics approaches , 2012, Biotechnology progress.

[74]  Steven M Cramer,et al.  Improved process analytical technology for protein a chromatography using predictive principal component analysis tools , 2011, Biotechnology and bioengineering.